Cullen Investment Group’s Pfizer PFE Stock Holding History

Cullen Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$380K	Sell	15,768 -327	-2%	-$8.55K	0.05%	148
2026 Q1	$452K	Sell	16,095 -2,803	-15%	-$74.6K	0.06%	137
2025 Q4	$482K	Sell	18,898 -3,658	-16%	-$92.2K	0.06%	131
2025 Q3	$617K	Sell	22,556 -8,027	-26%	-$198K	0.08%	118
2025 Q2	$741K	Sell	30,583 -5,186	-14%	-$121K	0.1%	113
2025 Q1	$906K	Sell	35,769 -5,154	-13%	-$135K	0.14%	107
2024 Q4	$1.09M	Sell	40,923 -1,754	-4%	-$47.6K	0.16%	102
2024 Q3	$1.24M	Buy	42,677 +377	+0.9%	+$11K	0.18%	95
2024 Q2	$1.18M	Sell	42,300 -3,420	-7%	-$94.2K	0.19%	92
2024 Q1	$1.26M	Sell	45,720 -5,827	-11%	-$162K	0.2%	94
2023 Q4	$1.48M	Buy	+51,547	New	+$1.56M	0.26%	82

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Cullen Investment Group's PFE Position: Q2 2026 in Review

Cullen Investment Group reduced its Pfizer (PFE) stake by 2% in Q2 2026, selling an estimated $8.55K and leaving 15,768 shares worth $380K. The position accounts for 0.05% of the portfolio, ranked #148.

Cullen Investment Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.48M in Q4 2023. 721 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cullen Investment Group held 15,768 shares of Pfizer worth $380K as of Q2 2026.
Cullen Investment Group sold 327 Pfizer shares in Q2 2026, an estimated $8.55K.
Pfizer made up 0.05% of Cullen Investment Group's portfolio in Q2 2026, its #148 holding.
Cullen Investment Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Cullen Investment Group's Pfizer position peaked at $1.48M in Q4 2023.
721 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.